DRRX - DURECT CORP
1.91
-0.020 -1.047%
Share volume: 2,787,659
Last Updated: 09-10-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$1.93
-0.02
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | |
| Report Date | 05-14-2024 | 08-14-2024 | 11-14-2024 | 03-27-2025 | 05-14-2025 | 08-13-2025 | |
| Total revenue | 1.827 M | 2.171 M | 1.927 M | -3.894 M | 321.000 K | 447.000 K | |
| Cost of revenue | 289.000 K | 356.000 K | 513.000 K | -1.080 M | 0.000 | 7.000 K | |
| Gross profit | 1.538 M | 1.815 M | 1.414 M | -2.814 M | 321.000 K | 440.000 K | |
| 18.01% | -22.09% | -299.01% | 111.41% | 37.07% | |||
| Operating expenses | 7.255 M | 5.219 M | 5.381 M | 3.010 M | 4.460 M | 3.243 M | |
| Selling general and admin | 3.136 M | 2.972 M | 3.217 M | 1.157 M | 2.577 M | 2.067 M | |
| Research and development | 4.119 M | 2.247 M | 2.164 M | 1.853 M | 1.883 M | 1.176 M | |
| Total expenses | 7.255 M | 5.219 M | 5.381 M | 3.010 M | 4.460 M | 3.243 M | |
| -28.06% | 3.10% | -44.06% | 48.17% | -27.29% | |||
| Operating income | -5.717 M | -3.404 M | -3.967 M | -5.824 M | -4.139 M | -2.803 M | |
| Ebit | -7.643 M | -3.700 M | -4.285 M | -2.786 M | -4.163 M | -2.265 M | |
| Pretax income | -7.643 M | -3.700 M | -4.285 M | -2.786 M | -4.163 M | -2.265 M | |
| -51.59% | 15.81% | -34.98% | 49.43% | -45.59% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -7.643 M | -3.700 M | -4.285 M | 7.304 M | -4.232 M | -2.265 M | |
| 51.59% | -15.81% | 270.46% | -157.94% | 46.48% |